The budgetary impact of alemtuzumab in multiple sclerosis in Quito, Ecuador. Payer's perspective.
Glob Reg Health Technol Assess
; 8: 140-146, 2021.
Article
in En
| MEDLINE
| ID: mdl-36627868
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Health_economic_evaluation
Aspects:
Patient_preference
Country/Region as subject:
America do sul
/
Ecuador
Language:
En
Journal:
Glob Reg Health Technol Assess
Year:
2021
Document type:
Article
Country of publication:
Italy